Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nowara

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Anatomical Record|January 1, 1982
Organ distribution and fate of newly formed splenic lymphocytes in the pigR Pabst, E Nowara
Archives of Oto-Rhino-Laryngology|January 1, 1984
The emigration of lymphocytes from palatine tonsils after local labellingR Pabst, E Nowara
HNO|April 1, 1986
[The palatal tonsils as a part of the lymphatic system. Inflow and outflow of newly-formed lymphocytes]E Nowara, R Pabst
Przeglad Lekarski|January 1, 1995
[Non Hodgkin's lymphoma of the breast]E Nowara, S Szelc, D Syguła, et al.
Otolaryngologia Polska = the Polish Otolaryngology|January 1, 1997
[Primary non-Hodgkin's lymphoma of the maxillary sinus]E Nowara, S Szelc, D Syguła, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)A Awada, I N Bondarenko, J Bonneterre, et al.
Bone Marrow Transplantation|January 8, 2013
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizersS Giebel, T Kruzel, T Czerw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancerG Deplanque, M Demarchi, M Hebbar, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2013
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancerA L Cohn, J Tabernero, J Maurel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Anatomical Record|January 1, 1982
Organ distribution and fate of newly formed splenic lymphocytes in the pigR Pabst, E Nowara
Archives of Oto-Rhino-Laryngology|January 1, 1984
The emigration of lymphocytes from palatine tonsils after local labellingR Pabst, E Nowara
HNO|April 1, 1986
[The palatal tonsils as a part of the lymphatic system. Inflow and outflow of newly-formed lymphocytes]E Nowara, R Pabst
Przeglad Lekarski|January 1, 1995
[Non Hodgkin's lymphoma of the breast]E Nowara, S Szelc, D Syguła, et al.
Otolaryngologia Polska = the Polish Otolaryngology|January 1, 1997
[Primary non-Hodgkin's lymphoma of the maxillary sinus]E Nowara, S Szelc, D Syguła, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)A Awada, I N Bondarenko, J Bonneterre, et al.
Bone Marrow Transplantation|January 8, 2013
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizersS Giebel, T Kruzel, T Czerw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2015
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancerG Deplanque, M Demarchi, M Hebbar, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2013
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancerA L Cohn, J Tabernero, J Maurel, et al.
Pageof 1